Eric Kissi

Title: The Innovative Contributions of Eric Kissi

Introduction

Eric Kissi is a notable inventor based in Helsinki, Finland. He has made significant strides in the field of pharmaceuticals, particularly through his innovative methods for crystallization of active pharmaceutical ingredients (APIs). His work has the potential to enhance the efficiency and effectiveness of drug formulations.

Latest Patents

Eric Kissi holds a patent for a method that focuses on the crystallization of active pharmaceutical ingredients. This patent describes a process where solid amorphous nanosized APIs are contacted with an aqueous solution containing one or more polymers and/or copolymers. The result is a suspension that comprises nanosized APIs in crystalline form, allowing for controlled crystallization and crystal growth.

Career Highlights

Kissi is currently employed at Nanoform Finland Oyj, a company that specializes in nanotechnology for pharmaceuticals. His work at Nanoform has positioned him as a key player in the development of advanced drug delivery systems. His innovative approach to crystallization is expected to contribute significantly to the pharmaceutical industry.

Collaborations

Eric Kissi collaborates with talented professionals in his field, including Martti Kaasalainen and Tatiana Danilova. These collaborations enhance the research and development efforts at Nanoform, fostering an environment of innovation and creativity.

Conclusion

Eric Kissi's contributions to the field of pharmaceuticals through his innovative crystallization methods demonstrate his commitment to advancing drug formulation technologies. His work at Nanoform Finland Oyj and his collaborations with other professionals highlight the importance of teamwork in driving innovation.